The company also will send letters to thousands of U.S. physicians notifying them of the risk similar to a letter it sent to Canadian physicians and pharmacists last October. The drug is approved only for schizophrenia, but is often used with elderly patients suffering from dementia and Alzheimer’s.
New drug warning
Johnson & Johnson said it plans to change the package insert of its second-best selling medicine, the antipsychotic drug Risperdal, to warn of a possible increased risk of stroke for elderly patients.
May 31, 2003
Recommended
Recommended
Machinery Basics
Get a jump on your 2026 packaging & processing goals at PACK EXPO East.
Be the first to find what’s next in packaging & processing at PACK EXPO East. See new solutions from 500 exhibitors, uncover creative ideas for 40+ verticals and gain inspiration from free sessions on industry trends—all in one trip to Philadelphia.
REGISTER NOW & SAVE
Annual Outlook Report: Workforce
Hiring remains a major challenge in packaging, with 78% struggling to fill unskilled roles and 84% lacking experienced workers. As automation grows, companies must rethink hiring and training. Download the full report for key insights.
Download Now
Downloads
